DK400884A - Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden - Google Patents
Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden Download PDFInfo
- Publication number
- DK400884A DK400884A DK400884A DK400884A DK400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A
- Authority
- DK
- Denmark
- Prior art keywords
- octahydropyrazolo
- quinolines
- tautomer
- alkylated
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53551983A | 1983-09-26 | 1983-09-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK400884D0 DK400884D0 (da) | 1984-08-22 |
DK400884A true DK400884A (da) | 1985-03-27 |
Family
ID=24134591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK400884A DK400884A (da) | 1983-09-26 | 1984-08-22 | Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0145121B1 (fr) |
JP (4) | JPS6110583A (fr) |
KR (1) | KR870001159B1 (fr) |
CA (1) | CA1270488A (fr) |
DE (1) | DE3484925D1 (fr) |
DK (1) | DK400884A (fr) |
GB (1) | GB2146984B (fr) |
GR (1) | GR80200B (fr) |
HU (1) | HU199836B (fr) |
IL (1) | IL72729A (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6392722A (ja) * | 1986-10-03 | 1988-04-23 | Unitika Ltd | 熱接着繊維およびその不織布 |
JPS6392723A (ja) * | 1986-10-06 | 1988-04-23 | Unitika Ltd | 湿潤性複合繊維およびその不織布 |
JPS6420322A (en) * | 1987-07-13 | 1989-01-24 | Mitsubishi Petrochemical Co | Conjugated fiber |
JPH01204617A (ja) * | 1988-02-09 | 1989-08-17 | Chisso Corp | 敷物 |
GB8828669D0 (en) * | 1988-12-08 | 1989-01-11 | Lilly Industries Ltd | Organic compounds |
KR20000008130A (ko) * | 1998-07-10 | 2000-02-07 | 조정래 | 폴리에스터계 탄성사용 공중합물의 제조방법 |
JP2014501785A (ja) | 2011-01-07 | 2014-01-23 | コーセプト セラピューティクス, インコーポレイテッド | ステロイドおよびグルココルチコイド受容体アンタゴニスト組合せ治療 |
WO2013130420A1 (fr) * | 2012-02-27 | 2013-09-06 | Corcept Therapeutics, Inc. | Modulateurs du récepteur des glucocorticoïdes à base de phényl-hétérocycloalkyle |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
PL3560493T3 (pl) | 2013-11-25 | 2021-10-04 | Corcept Therapeutics Incorporated | Skondensowane oktahydroazadekaliny będące modulatorami receptora glukokortykoidowego |
JP2020515563A (ja) | 2017-03-31 | 2020-05-28 | コーセプト セラピューティクス, インコーポレイテッド | 子宮頸がんを処置するためのグルココルチコイドレセプターモジュレーター |
BR112021010461A2 (pt) | 2018-12-19 | 2021-08-24 | Corcept Therapeutics Incorporated | Formulação e dose unitária para administração oral de relacorilante |
US11234971B2 (en) | 2018-12-19 | 2022-02-01 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
US11389432B2 (en) | 2018-12-19 | 2022-07-19 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
CN113490496A (zh) | 2019-02-22 | 2021-10-08 | 科赛普特治疗学股份有限公司 | 一种杂芳基-酮稠合氮杂萘烷糖皮质激素受体调节剂瑞拉可兰的治疗用途 |
CA3158745A1 (fr) | 2019-12-11 | 2021-06-17 | Corcept Therapeutics Incorporated | Methodes de traitement d'une prise de poids induite par medicaments antipsychotiques avec du miricorilant |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
US4230861A (en) * | 1979-01-22 | 1980-10-28 | Eli Lilly And Company | 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids |
SU776048A1 (ru) * | 1979-06-05 | 1983-09-23 | Институт Бисорганической Химии Ан Бсср | Производные 8-аза-16-оксагона-17-онов, про вл ющие противовоспалительную,мембраностабилизирующую и антифибринолитическую активность,и способ их получени |
US4252945A (en) * | 1979-07-11 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Process for preparing pyrazolo[1,5-c]-quinazoline derivatives and novel intermediates |
US4367231A (en) * | 1979-09-14 | 1983-01-04 | Eli Lilly And Company | Method of using octahydro pyrazolo[3,4-g]quinolines |
ES524452A0 (es) * | 1982-11-03 | 1985-04-16 | Lilly Co Eli | Un procedimiento para la preparacion de derivados de pirazolo-quinolinas. |
-
1984
- 1984-08-20 CA CA000461330A patent/CA1270488A/fr not_active Expired - Lifetime
- 1984-08-20 IL IL72729A patent/IL72729A/xx unknown
- 1984-08-21 DE DE8484305685T patent/DE3484925D1/de not_active Expired - Lifetime
- 1984-08-21 EP EP84305685A patent/EP0145121B1/fr not_active Expired - Lifetime
- 1984-08-21 GB GB08421159A patent/GB2146984B/en not_active Expired
- 1984-08-22 DK DK400884A patent/DK400884A/da not_active Application Discontinuation
- 1984-08-22 HU HU843161A patent/HU199836B/hu not_active IP Right Cessation
- 1984-08-23 GR GR80200A patent/GR80200B/el unknown
- 1984-08-24 JP JP59177382A patent/JPS6110583A/ja active Granted
- 1984-08-24 KR KR1019840005148A patent/KR870001159B1/ko not_active IP Right Cessation
-
1992
- 1992-09-16 JP JP4246412A patent/JPH05194511A/ja active Pending
- 1992-09-16 JP JP4246442A patent/JPH0625251A/ja active Pending
- 1992-09-16 JP JP4246440A patent/JPH0660183B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0625251A (ja) | 1994-02-01 |
HUT34750A (en) | 1985-04-28 |
JPH0660183B2 (ja) | 1994-08-10 |
DE3484925D1 (de) | 1991-09-19 |
KR850002480A (ko) | 1985-05-13 |
GB2146984B (en) | 1987-04-08 |
HU199836B (en) | 1990-03-28 |
JPH05194511A (ja) | 1993-08-03 |
EP0145121A3 (en) | 1988-04-27 |
CA1270488A (fr) | 1990-06-19 |
JPH0568475B2 (fr) | 1993-09-29 |
IL72729A0 (en) | 1984-11-30 |
EP0145121A2 (fr) | 1985-06-19 |
JPS6110583A (ja) | 1986-01-18 |
DK400884D0 (da) | 1984-08-22 |
GR80200B (en) | 1985-01-02 |
GB2146984A (en) | 1985-05-01 |
GB8421159D0 (en) | 1984-09-26 |
IL72729A (en) | 1988-02-29 |
EP0145121B1 (fr) | 1991-08-14 |
KR870001159B1 (ko) | 1987-06-13 |
JPH05194527A (ja) | 1993-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK164684D0 (da) | 4-substituerede-2-azetidinon-forbindelser,fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved | |
DK400884A (da) | Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden | |
NO854826L (no) | Fremgangsmaate og apparat for broennboring. | |
DK381485D0 (da) | 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf | |
DK445884D0 (da) | Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden | |
DK137083D0 (da) | Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholecalciferol og mellemprodukter til brug herved | |
DK321382A (da) | Lineaere basiske polymerisater og fremgangsmaade til fremstilling heraf | |
DK178084D0 (da) | 1,3-dihydro-6-methyl-7-hydrosyfuro-(3,4-c)-pyridinderivater og fremgangsmade til fremstilling deraf | |
DK385884A (da) | 2,6-substituerede 3,5-pyridin-dicarboxylsyre-derivater og fremgangsmaade til fremstilling heraf | |
DK172485D0 (da) | 23,23-difluor-1,25-dihydroxycholecalciferol og derivater deraf, fremgangsmaade til fremstilling af disse og mellemprodukter til brug herved | |
DK32684D0 (da) | Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor | |
DK511884D0 (da) | Leukotrienantagonister og fremgangsmaade til fremstilling deraf | |
NO864411L (no) | Fremgangsmaate og innretning for kontinuerlig strenggrafittering av karbon-formlegemer. | |
PL232330A1 (en) | Method of obtaining new derivatives of oxazolidinodione-2,4 | |
DK416888D0 (da) | Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser | |
DK165952C (da) | 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf | |
PL253821A1 (en) | Method of obtaining derivatives of 1,4-dihydropyridine | |
NO812493L (no) | Metode for aa aapne, sammenfolde og rotere stive baatseil | |
DK406484A (da) | 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf | |
DK69684D0 (da) | 2(1h)-pyridinonforbindelser og fremgangsmade til fremstilling heraf | |
IS2902A7 (is) | Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis | |
DK52885D0 (da) | 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf | |
DK449388A (da) | Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden | |
NO159764C (no) | Fremgangsmaate og anordning ved fremstilling av pariserpoteter. | |
DK127182A (da) | Fremgangsmaade til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-(2-phenylacetamido)penicillanater og mellemprodukter herved |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |